A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...

The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded ...

Milestone Pharmaceuticals (MIST) announced that it has received Notice of Allowance from the United States Patent and Trademark Office, or ...

The kits include two Narcan nasal spray devices with instructions for the proper administration and steps to be taken in the ...

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has ...

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

The FDA reviews drug approval decisions that are expected in March 2025. The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled ...

The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...

Letters to the editors for the November 2024 issue of Scientific American ...

Many recalls come as a result of product mislabeling, safety issues or contamination. Here are five recalls in particular ...